Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe

Courtney Davis, Anita K Wagner, Maximilian Salcher-Konrad, Henry Scowcroft, Barbara Mintzes, Adrian M J Pokorny, Jianhui Lew, Huseyin Naci

Open source

DOI
10.1136/bmj-2022-073711
Published
2023-03-29
Container
BMJ
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmj-2022-073711,
  title = {Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe},
  author = {Courtney Davis and Anita K Wagner and Maximilian Salcher-Konrad and Henry Scowcroft and Barbara Mintzes and Adrian M J Pokorny and Jianhui Lew and Huseyin Naci},
  year = {2023},
  journal = {BMJ},
  doi = {10.1136/bmj-2022-073711},
  url = {https://doi.org/10.1136/bmj-2022-073711}
}

RIS

TY  - JOUR
TI  - Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe
AU  - Courtney Davis
AU  - Anita K Wagner
AU  - Maximilian Salcher-Konrad
AU  - Henry Scowcroft
AU  - Barbara Mintzes
AU  - Adrian M J Pokorny
AU  - Jianhui Lew
AU  - Huseyin Naci
PY  - 2023
JO  - BMJ
DO  - 10.1136/bmj-2022-073711
UR  - https://doi.org/10.1136/bmj-2022-073711
ER  - 

APA

Davis, C., Wagner, A. K., Salcher-Konrad, M., Scowcroft, H., Mintzes, B., Pokorny, A. M. J., Lew, J., & Naci, H. (2023). Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. BMJ. https://doi.org/10.1136/bmj-2022-073711

Source records